Kunwar Shailubhai
Corporate Officer/Principal bei Baruch S. Blumberg Institute
Aktive Positionen von Kunwar Shailubhai
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Baruch S. Blumberg Institute | Corporate Officer/Principal | - | - |
Karriereverlauf von Kunwar Shailubhai
Ehemalige bekannte Positionen von Kunwar Shailubhai
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TIZIANA LIFE SCIENCES LTD | Vorstandsvorsitzender | - | 01.08.2022 |
| Technik-/Wissenschafts-/F&E-Leiter | - | 01.08.2022 | |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | 01.01.2008 | 01.08.2022 |
| Vorstandsvorsitzender | 01.01.2008 | - | |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2008 | 15.07.2022 | |
| ACCUSTEM SCIENCES, INC. | Direktor/Vorstandsmitglied | - | 20.06.2022 |
| OKYO PHARMA LIMITED | Direktor/Vorstandsmitglied | 06.07.2017 | 17.06.2021 |
| ACTAVIA LIFE SCIENCES, INC. | Direktor/Vorstandsmitglied | 01.08.2016 | 23.12.2020 |
| Vorstandsvorsitzender | 21.04.2017 | 06.02.2020 | |
| Independent Dir/Board Member | 01.08.2016 | 21.04.2017 | |
| SYNERGY PHARMACEUTICALS INC | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2008 | 01.05.2017 |
| Gründer | 01.01.2001 | 01.05.2017 | |
| Corporate Officer/Principal | 01.01.2001 | 01.07.2008 | |
| Pawfect Foods, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - | 11.08.2008 |
Drug Discovery Facility
 Drug Discovery Facility Pharmaceuticals: MajorHealth Technology Part of SCYNEXIS, Inc., Drug Discovery Facility provides research into drug-discovery processes. The company is based in Cambridge, UK. Drug Discovery Facility was acquired by SCYNEXIS, Inc. from Aventis Cropscience on October 02, 2001. | Corporate Officer/Principal | 01.01.2003 | 01.01.2008 |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von Kunwar Shailubhai
| University of Baroda | Doctorate Degree |
| University of Missouri | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 9 |
| Vereinigtes Königreich | 4 |
| Indien | 2 |
Operativ
| Corporate Officer/Principal | 5 |
| Director/Board Member | 5 |
| Chief Tech/Sci/R&D Officer | 4 |
Sektoral
| Health Technology | 9 |
| Consumer Services | 4 |
| Retail Trade | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Health Technology |
| OKYO PHARMA LIMITED | Health Technology |
| ACCUSTEM SCIENCES, INC. | Health Technology |
| TIZIANA LIFE SCIENCES LTD | Health Technology |
| Private Unternehmen | 7 |
|---|---|
| Pawfect Foods, Inc. | Retail Trade |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
| Baruch S. Blumberg Institute | |
Active With Me, Inc.
 Active With Me, Inc. Miscellaneous Commercial ServicesCommercial Services Active With Me, Inc. provides online resources that seamlessly offer travelers unique, highly relevant and user-friendly information on activity-based travel. Its listings will be provided for product and service providers of interest to the activity-based traveler. The company was founded on December 6, 2012 and is headquartered in Sarnia, Canada. | Commercial Services |
Drug Discovery Facility
Drug Discovery Facility Pharmaceuticals: MajorHealth Technology Part of SCYNEXIS, Inc., Drug Discovery Facility provides research into drug-discovery processes. The company is based in Cambridge, UK. Drug Discovery Facility was acquired by SCYNEXIS, Inc. from Aventis Cropscience on October 02, 2001. | Health Technology |
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Health Technology |
- Börse
- Insiders
- Kunwar Shailubhai
- Erfahrung
